Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Shares Outstanding (2016 - 2025)

Mimedx's Shares Outstanding history spans 11 years, with the latest figure at $112.7 million for Q4 2021.

  • For Q4 2021, Shares Outstanding changed 0.0% year-over-year to $112.7 million; the TTM value through Dec 2021 reached $112.7 million, changed 0.0%, while the annual FY2021 figure was $112.7 million, 6254.23% up from the prior year.
  • Shares Outstanding for Q4 2021 was $112.7 million at Mimedx, up from $1.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $112.7 million in Q3 2017 and bottomed at $72243.0 in Q2 2017.
  • The 5-year median for Shares Outstanding is $58.3 million (2017), against an average of $57.2 million.
  • The largest YoY upside for Shares Outstanding was 151502.42% in 2017 against a maximum downside of 98.49% in 2017.
  • A 5-year view of Shares Outstanding shows it stood at $112.7 million in 2017, then changed by 0.0% to $112.7 million in 2018, then crashed by 98.33% to $1.9 million in 2019, then soared by 5878.11% to $112.7 million in 2020, then changed by 0.0% to $112.7 million in 2021.
  • Per Business Quant, the three most recent readings for MDXG's Shares Outstanding are $112.7 million (Q4 2021), $1.1 million (Q1 2021), and $112.7 million (Q4 2020).